The Boston Globe, October 21, 2010

Beth Israel Deaconess Medical Center temporarily closed all its cancer trials to new patients last week, after audits found that several researchers had not properly submitted patient data to the committee that oversees oncology research and to trial sponsors.

“Some of our clinical trials were not running with the high standards that we expect,’’ Randy Mason, vice president of research operations, wrote in an e-mail to hospital executives and physician leaders last week.

He described the lapses as involving documentation and reporting compliance and said the hospital has not found any “issues of patient harm.’’

Facebook icon
LinkedIn icon
Twitter icon